Cannabis and Hemp Industry Investment News
To date, the Ontario-based company says C$1.3 million in proceeds have been committed and received The net proceeds will be used for the expansion of ...
What are you searching for? Cannabis stocks were broadly flat on Wednesday, after a drop on Tuesday and a rocky few months for the industry. The Nort...
What are you searching for? viewFSD Pharma Inc () (OTCQB:FSDDF) subsidiary FV Pharma president, Dr Sara May tells Proactive the Canada-based company h...
What are you searching for? viewFSD Pharma Clients with a prescription or a registration number with Health Canada can place an order online for dried...
The firm has had a busy 2019, as it continues its rapid expansion at its facility, while also pushing forward its research and development platform FS...
The new appointments come as the medical cannabis company advances its efforts to pursue development of CBD-based therapies to replace widely used opi...
What are you searching for? viewFSD Pharma Inc (CSE: HUGE) (OTCMKTS:FSDDF) President Edward Brennan tells Proactive Investors the cannabis focused com...
What are you searching for? viewAusCann Group Holdings Ltd The purchase follows the recent appointment to CEO of ex Teva Pharmaceutical executive, Ido...
Ido Kanyon will replace interim CEO Dr Paul MacLeman on 22 May 2019. NYSE-listed Teva Pharmaceutical generated over $20 billion in revenue in FY17 () ...
AC8 has all the necessary licenses to grow and manufacture cannabinoid medicines in Australia. The company's first product line is medicinal cannabis ...
() (OTCQX:ACNNF) aims to produce high-quality, economical, and clinically-validated cannabinoid medicines. It has a vertically integrated strategy beg...
Quentin Megson will serve jointly in the role with existing company secretary Susan Hunter. The company aims to produce high-quality and clinically va...
The facility will support the development of existing and new cannabinoid formulations. AusCann holds the full set of necessary licences to grow and m...
DayaCann is a 50:50 joint venture formed by AusCann and Chilean partner Fundación Daya. Khiron will pay DayaCann US$1.2 million () through its DayaCan...
Executive director Dr Paul MacLeman will act as interim CEO from January 1, 2019 until a full-time appointment is made by the board. The company is ex...
The company's first product line is medicinal cannabis hard shell capsules. The proprietary solid hard shell capsules are for the treatment of chronic...
What are you searching for? viewAusCann Group Holdings Ltd The online education resources aim to bring awareness to medical professionals. Yesterday, ...
The companies will collaborate on activities to develop cannabinoid medicines as a medical option in Chile. Khiron is listed on the TSX Venture Exchan...
AusCann is transitioning from a start-up company focused on product development to a pharmaceutical production and sales business. Dr MacLeman has ove...
The company aims to release its first medicinal cannabis products in FY2019. The cannabis sector in the US is gaining investor's attention () (OTCQX:A...
